ObjectiveRecovery of motor function is important for regaining independence after stroke, but difficult to predict for individual patients. Our aim was to develop an efficient, accurate, and accessible algorithm for use in clinical settings. Clinical, neurophysiological, and neuroimaging biomarkers of corticospinal integrity obtained within days of stroke were combined to predict likely upper limb motor outcomes 3 months after stroke.MethodsData from 207 patients recruited within 3 days of stroke [103 females (50%), median age 72 (range 18–98) years] were included in a Classification and Regression Tree analysis to predict upper limb function 3 months poststroke.ResultsThe analysis produced an algorithm that sequentially combined a measure of upper limb impairment; age; the presence or absence of upper limb motor evoked potentials elicited with transcranial magnetic stimulation; and stroke lesion load obtained from MRI or stroke severity assessed with the NIHSS score. The algorithm makes correct predictions for 75% of patients. A key biomarker obtained with transcranial magnetic stimulation is required for one third of patients. This biomarker combined with NIHSS score can be used in place of more costly magnetic resonance imaging, with no loss of prediction accuracy.InterpretationThe new algorithm is more accurate, efficient, and accessible than its predecessors, which may support its use in clinical practice. While further work is needed to potentially incorporate sensory and cognitive factors, the algorithm can be used within days of stroke to provide accurate predictions of upper limb functional outcomes at 3 months after stroke. www.presto.auckland.ac.nz

No abstract

It has been well documented that marked improvements in the hypokinetic gait pattern of Parkinson's disease patients are possible with the use of appropriate visual cues. This project served to evaluate Parkinson's disease gait performance as well as residual processing capacity while using fixed or gait-regulated visual cues. Three-dimensional kinematic, kinetic and electromyographic gait analysis was carried out on 14 patients and 14 matched controls in baseline conditions and with two types of visual cues: taped step length (SL) markers and an individualized subject-mounted light device (SMLD). A probe reaction time paradigm was invoked to assess residual processing capacity. Ratings of perceived task load were also made using the NASA-Task Load Index. Stride length and gait velocity were reduced in patients in baseline conditions. Both of these parameters increased to control levels with the use of visual cues. These alterations were generally accompanied by modifications of lower limb kinematics and kinetics towards control subjects. Perceived task load was higher in all conditions and was further elevated by the use of the SMLD for both groups. Patients produced larger overall reaction times, although reaction time was not different between baseline and SL marker conditions. Reaction time was increased in both groups when using the SMLD. The overarching finding is that stride length can be regulated in Parkinson's disease using stationary visual cues without increased central processing capacity or perceived effort. This may occur via utilization of visual feedback, reducing the patients' reliance on kinaesthetic feedback for the regulation of movement amplitude.

URL: http://anzctr.org.au. Unique identifier: ACTRN12611000755932.

URL: http://www.anzctr.org.au. Unique identifier: ANZCTR12611000755932.

LL impairment resolves by ≈70% within 3 months after stroke. The absence of a nonfitter group may be because of differences in the neuroanatomical organization of descending motor tracts to the upper limb and LL. Proportional recovery of the LL is not influenced by therapy dose providing further evidence that it reflects a fundamental biological process.

No abstract

Background and Purpose— The ability to live independently after stroke depends on the recovery of upper limb function. We hypothesized that bilateral priming with active–passive movements before upper limb physiotherapy would promote rebalancing of corticomotor excitability and would accelerate upper limb recovery at the subacute stage. Methods— A single-center randomized controlled trial of bilateral priming was conducted with 57 patients randomized at the subacute stage after first-ever ischemic stroke. The PRIMED group made device-assisted mirror symmetrical bimanual movements before upper limb physiotherapy, every weekday for 4 weeks. The CONTROL group was given intermittent cutaneous electric stimulation of the paretic forearm before physiotherapy. Assessments were made at baseline, 6, 12, and 26 weeks. The primary end point was the proportion of patients who reached their plateau for upper limb function at 12 weeks, measured with the Action Research Arm Test. Results— Odds ratios indicated that PRIMED participants were 3× more likely than controls to reach their recovery plateau by 12 weeks. Intention-to-treat and per-protocol analyses showed a greater proportion of PRIMED participants achieved their plateau by 12 weeks (intention to treat, χ 2 =4.25; P =0.039 and per protocol, χ 2 =3.99; P =0.046). ANOVA of per-protocol data showed PRIMED participants had greater rebalancing of corticomotor excitability than controls at 12 and 26 weeks and interhemispheric inhibition at 26 weeks (all P <0.05). Conclusions— Bilateral priming accelerated recovery of upper limb function in the initial weeks after stroke. Clinical Trial Registration— URL: http://www.anzctr.org.au . Unique identifier: ANZCTR1260900046822.